Roche sues Biocon, Mylan, DCGI over breast cancer drug

Roche has sued Mylan, Biocon for launching biosimilar version of the original breast cancer drug, Herceptin, and DCGI for allowing the launch.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news